12 F.4th 1
1st Cir.2021Background
- Insys Therapeutics marketed Subsys, an FDA-approved fentanyl spray for breakthrough cancer pain; executives (Kapoor, Lee, Simon, Rowan, Gurry) implemented aggressive sales tactics including speaker payments (kickbacks), quota/‘push the dose’ programs, and an in-house Insys Reimbursement Center (IRC) that obtained prior authorizations by using misleading or false information.
- A federal RICO indictment charged five executives (after two co-defendants pleaded guilty) with conspiracy to conduct the enterprise’s affairs through patterns of racketeering, alleging predicate acts of mail fraud, wire fraud, honest-services fraud, and Controlled Substances Act (CSA) violations.
- After a 51‑day trial the jury convicted the five defendants on most counts; the district court later vacated CSA and honest‑services predicate findings as to four defendants (Kapoor, Lee, Simon, Rowan) under the “equipoise” standard but left mail/wire fraud convictions intact for all five; sentences were imposed and the court ordered restitution and forfeiture.
- On appeal the First Circuit reinstated the vacated CSA and honest‑services predicate findings (finding the evidence sufficient and the equipoise principle inapplicable), affirmed convictions and sentences, upheld evidentiary rulings (including admission of limited patient‑harm testimony), rejected spillover and severance claims, but vacated and remanded certain restitution and forfeiture calculations for further proceedings.
- The Court emphasized that (1) defendants knowingly targeted high‑volume prescribers ("whales"), courted pill‑mill doctors, paid speaker fees tied to prescriptions/doses, and directed IRC tactics to obtain insurer approvals by misrepresentations; (2) these actions supported RICO predicates including CSA and honest‑services fraud; and (3) monetary remedies must be tied to provable losses and properly apportioned.
Issues
| Issue | Government's Argument | Defendants' Argument | Held |
|---|---|---|---|
| Sufficiency of evidence for CSA and honest‑services predicates (Kapoor, Lee, Simon, Rowan) | Evidence (whale targeting, pill‑mill recruitment, dose‑pushing, direct‑ship deals, IRC deception) shows defendants intended illegitimate prescriptions and fiduciary breaches by prescribers | Evidence was equivocal; district court erred in denying acquittal because inferences for guilt and innocence were balanced | Reinstated jury findings; evidence sufficient and equipoise inapplicable — convictions on those predicates stand |
| Sufficiency of evidence for mail‑ and wire‑fraud predicates | Mailed speaker payments and mailings of bribes were part of scheme that generated prescriptions processed through IRC; wire/mail use furthered scheme | Mailings did not materially further IRC misrepresentations and indictment was constructively amended | Affirmed convictions; mailing/wire use was "in furtherance" and no constructive amendment occurred |
| Admissibility of patient‑harm testimony & spillover (including Gurry) | Patient testimony about addiction/withdrawal was relevant to show prescriptions were outside professional practice and to show scheme effects; limited inflammatory detail | Testimony was irrelevant, unfairly prejudicial, cumulative, and caused spillover to acquitted predicates | District court did not abuse discretion admitting limited patient testimony; no prejudicial spillover — jury verdicts stood (acquittal on some predicates for Gurry supports lack of spillover) |
| Restitution and forfeiture calculations | Restitution to insurers and forfeiture of defendants’ proceeds are appropriate to compensate victims and forfeit criminal proceeds | District court overstated restitution (awarded 100% of claims for thirteen bribed doctors despite evidence IRC processed ~80.9% of prescriptions); tax offsets and whole‑salary forfeitures challenged | Convictions affirmed, but restitution and forfeiture orders (except Kapoor’s forfeiture) vacated/remanded: restitution must be tied to actual losses (but a modest evidentiary standard); forfeiture must prorate tainted proceeds and no tax offsets allowed |
Key Cases Cited
- Salinas v. United States, 522 U.S. 52 (defendant need not facilitate every element of substantive offense for RICO conspiracy)
- Skilling v. United States, 561 U.S. 358 (honest‑services fraud requires bribery or kickback in violation of fiduciary duty)
- Moore v. United States, 423 U.S. 122 (CSA liability where prescribing falls outside usual course of professional practice)
- Schmuck v. United States, 489 U.S. 705 (mailing is in furtherance if incident to an essential part of the scheme)
- Burgos v. United States, 703 F.3d 1 (First Circuit discussion of "equipoise" rule on sufficiency review)
- Cadden v. United States, 965 F.3d 1 (forfeiture limited to proceeds tainted by racketeering; gross proceeds concept)
- Volkman v. United States, 797 F.3d 377 (intent to distribute where clinic prescriptions lack legitimate medical purpose)